Cubist Pharmaceuticals Inc. (CBST) News Nov 18, 2014, 5:23

New Post Public Reply Private Reply Replies (0) Message Board

Nov 18, 2014 at 9:54 PM

Cubist Pharmaceuticals Inc. (CBST) News Nov 18, 2014, 5:23 p.m.
MarketWatch News on CBST
Cubist completes exacta, gets good news from FDA two days in a row 6:22 p.m. June 20, 2014 - Russ Britt
Earnings roundup: Cubist, Merck gain as HCA, Bristol-Myers slide 10:48 a.m. April 29, 2014 - Russ Britt
Three biopharma companies poised for product OKs in 2014: analyst 12:51 p.m. Jan. 6, 2014 - Russ Britt
Cubist, Agenus shares soar after experimental drugs pass muster 1:20 p.m. Dec. 16, 2013 - Russ Britt
Cubist, Trius shares keep rocking, while Optimer and Amgen struggle 12:56 p.m. July 31, 2013 - Russ Britt
Cubist Pharmaceuticals adds fire to merger frenzy with two buyouts 5:00 p.m. July 30, 2013 - Russ Britt
Never mind earnings, it's revenue that drives Cubist shares higher 10:19 a.m. July 19, 2013 - Russ Britt
Cubist Q2 profit down 65% amid higher costs 3:39 p.m. July 18, 2013 - MarketWatch.com
Cubist Pharmaceuticals shares leap late after ruling on patent cases 4:16 p.m. May 20, 2013 - Russ Britt
A few wild stock swings in health earnings 4:34 p.m. Jan. 23, 2013 - Russ Britt
Updates, advisories and surprises 4:01 p.m. Oct. 18, 2012 - MarketWatch
Cubist Pharmaceuticals third-quarter net climbs 3:20 p.m. Oct. 18, 2012 - Russ Britt
FactSet estimate on Cubist is 47 cents 3:12 p.m. Oct. 18, 2012 - Russ Britt
Cubist revenue: $238.1 million vs. $201.7 million 3:07 p.m. Oct. 18, 2012 - Russ Britt
Cubust Pharma net 55 cents vs. 33 cents 3:06 p.m. Oct. 18, 2012 - Russ Britt
Charting a bull/bear stalemate 10:52 a.m. Aug. 23, 2012 - Michael Ashbaugh
Hot stocks to watch 7:59 a.m. July 20, 2012 - MarketWatch.com
Cubist Pharma projects annual sales of $2 bln 12:25 p.m. June 11, 2012 - MarketWatch.com
Cubist Pharma profit jumps 45% on Cubicin boost 4:30 p.m. April 18, 2012 - MarketWatch.com
Bearish bets on four stocks 12:46 p.m. April 9, 2012 - The Trading Deck
Loading more headlines...
Advertisement
Other News on CBST
Making Money With Charles Payne: 11/17/14 6:00 p.m. Nov. 17, 2014 - FOXBusiness
Cubist Pharmaceuticals Inc. (CBST): New Analyst Report from Zacks Equity Research - Zacks Equity Research Report 7:00 a.m. Nov. 14, 2014 - Zacks.com
10-Q: CUBIST PHARMACEUTICALS INC 9:04 a.m. Nov. 7, 2014 - Edgar Online - (EDG = 10Q, 10K)
Cubist Pharmaceuticals (CBST) Upgraded From Hold to Buy 9:14 a.m. Nov. 5, 2014 - TheStreet.com
Wedbush Initiates Coverage On Cubist Pharmaceuticals 10:09 a.m. Nov. 4, 2014 - benzinga.com
Biotech Stock Roundup: Beat & Raise Quarter for Amgen, Celgene, Alexion, Biogen - Analyst Blog 12:28 p.m. Oct. 29, 2014 - Zacks.com
Why We Think Cubist Pharmaceuticals Has Incredible Upside 4:34 a.m. Oct. 29, 2014 - Seeking Alpha
Biggest Movers in Healthcare Stocks Now – MNKD CBST INCY ISIS 1:15 p.m. Oct. 23, 2014 - InvestorPlace.com
Cubist Pharmaceuticals' Q3 Earnings Beat Expectations - Analyst Blog 10:00 a.m. Oct. 23, 2014 - Zacks.com
Trade-Ideas: Cubist Pharmaceuticals (CBST) Is Today's "Storm The Castle" Stock 2:30 p.m. Oct. 22, 2014 - TheStreet.com
Hottest Healthcare Stocks Now – ACHC BSX CBST GSK 8:15 a.m. Oct. 22, 2014 - InvestorPlace.com
Cubist Pharmaceuticals' (CBST) CEO Mike Bonney on Q3 2014 Results - Earnings Call Transcript 10:30 p.m. Oct. 21, 2014 - Seeking Alpha
Cubist net income up 167% 6:14 p.m. Oct. 21, 2014 - Seeking Alpha
Wall Street Breakfast: IBM To Unload Semiconductor Unit - Report 6:33 a.m. Oct. 20, 2014 - Seeking Alpha
Benzinga's Weekend M&A Chatter 8:58 p.m. Oct. 19, 2014 - benzinga.com
Ironwood Pharma begins linaclotide label expansion trial 9:52 a.m. Oct. 16, 2014 - Seeking Alpha
Actavis Expands Antibiotics Presence With Durata Buy 9:58 a.m. Oct. 6, 2014 - Investors Business Daily
InsiderInsights.com Daily Round Up 10/2/14: FGP, INFI, AGCO, OPK 10:14 a.m. Oct. 3, 2014 - Seeking Alpha
FDA approves Salix/Progenics' Relistor 6:07 p.m. Sept. 29, 2014 - Seeking Alpha
Ad Comm supports approval of Moventig for OIC 8:35 a.m. Sept. 26, 2014 - Seeking Alpha
Loading more headlines...
Press Releases on CBST
European Antibiotic Awareness Day Highlights Need for Urgent Action 1:00 a.m. Nov. 17, 2014 - BusinessWire - BZX
Cubist Names Dr. Patrick Vink Chief Operating Officer 7:32 a.m. Nov. 5, 2014 - BusinessWire - BZX
Cubist to Present at Jefferies 2014 Healthcare Conference 9:01 a.m. Nov. 3, 2014 - BusinessWire - BZX
Technical Data on Biotech Equities - Intrexon, Keryx Biopharma, Spectrum Pharma, Sangamo BioSciences, and Cubist Pharma 8:15 a.m. Oct. 21, 2014 - PR Newswire - PRF
Cubist Pharmaceuticals Names Robert J. Perez Chief Executive Officer 6:31 a.m. Oct. 20, 2014 - BusinessWire - BZX
Cubist to Announce Third Quarter 2014 Financial Results on Tuesday, October 21, 2014 8:01 a.m. Oct. 14, 2014 - BusinessWire - BZX
Cubist to Present New Data from Study of fidaxomicin in Children with Clostridium Difficile-Associated Diarrhea at IDWeek 2014 7:31 a.m. Oct. 8, 2014 - BusinessWire - BZX
Cubist Announces Continued Global Expansion with Opening of International Headquarters in Zurich 3:30 a.m. Sept. 18, 2014 - BusinessWire - BZX
Cubist to Present at Morgan Stanley Global Healthcare Conference 8:02 a.m. Aug. 25, 2014 - BusinessWire - BZX
Cubist Announces EMA Acceptance of Ceftolozane/Tazobactam Marketing Authorization Application for Review 6:30 a.m. Aug. 22, 2014 - BusinessWire - BZX
Cubist Pharmaceuticals Issues Voluntary Nationwide Recall of Nine Lots of CUBICIN (daptomycin for injection) 500 mg in 10 mL single use vials Following Complaints of Foreign Particulate Matter in Reconstituted Vials 8:05 a.m. Aug. 10, 2014 - BusinessWire - BZX
Cubist Pharmaceuticals Issues Voluntary U.S. Recall of Certain Lots of CUBICIN (daptomycin for injection) 500 mg in 10 mL single use vials Due to Presence of Particulate Matter 10:35 p.m. Aug. 6, 2014 - BusinessWire - BZX
Cubist Pharmaceuticals Issues Voluntary U.S. Recall of Certain Lots of CUBICIN (daptomycin for injection) 500 mg in 10 mL single use vials Due to Presence of Particulate Matter 10:35 p.m. Aug. 6, 2014 - BusinessWire - BZX
Biotech Equities Roundup -- Keryx Biopharma, Vertex Pharma, NPS Pharma, Cubist Pharma, and Idera Pharma 7:50 a.m. Aug. 6, 2014 - PR Newswire - PRF
Cubist’s Once-daily SIVEXTRO™ (tedizolid phosphate) Available for Physician and Hospital Order in I.V. and Oral Formulations 7:32 a.m. Aug. 5, 2014 - BusinessWire - BZX
Financial Results, Clinical Trial Initiations, Drug Designations, Appointments, and Study Results - Research Reports on Cubist, Jazz, InterMune, NPS Pharmaceuticals and ACADIA 8:00 a.m. July 30, 2014 - PR Newswire - PRF
Cubist to Present at August Investor Conference 8:00 a.m. July 28, 2014 - BusinessWire - BZX
Mark H.N. Corrigan, M.D., Julie H. McHugh, and William Hunter, M.D. to Serve on EPIRUS Board of Directors 10:50 a.m. July 15, 2014 - BusinessWire - BZX
Cubist to Announce Second Quarter 2014 Financial Results on Tuesday, July 22, 2014 8:01 a.m. July 15, 2014 - BusinessWire - BZX
Cidara Therapeutics - "Back to the Rodeo" 10:10 a.m. July 1, 2014 - ACCESSWIRE
Loading more headlines...

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Truss Financial Tackles Home Equity Closing Delays

Truss Financial Group's Bold Move Against Closing Delays In real estate, time is money. Even the most casual market observer could tell you delays can slice through a deal like a hot knife through butter. That's the headache home equity borrowers face, blindsided by closing delays that sneak up on them without warning. An Industry Bottleneck Finally Addressed Enter Truss...

Community Banks Missing $106B Lending Opportunity?

A Missed Opportunity for Community Banks It's a classic tale: community banks sleepwalking while big players snatch up low-hanging fruit right in their own backyards. According to the latest report by Cornerstone Advisors, commissioned by Teslar Software, these banks are essentially leaving $106 billion on the table when it comes to consumer lending. That's not just chump...

Pushing for National Liver Cancer Awareness in 2026

The Urgency of Liver Cancer Awareness Death doesn’t wait, does it? When liver cancer is the villain in question, every moment becomes precious because this beast doesn’t roar until it’s too late. Here we are in 2026, staring at nearly 31,000 annual deaths in the U.S. alone. But hope flickers with a new congressional resolution aiming to slap a bright spotlight on...

Skandia's Soundproofing Kit Expands to Brazil's Skies

Soundproofing Takes Off in Brazil Skandia has just pulled off a neat trick, earning the nod from Brazil's National Civil Aviation Agency (ANAC) for their King Air soundproofing kit. That means quieter skies ahead for operators of the King Air 200 and 300 series in Brazil. This is no small feat, folks; it's like finally getting that coveted backstage pass after years of...

Cala Launches Game-Changer Wearable for Tremor Relief

Breaking New Ground in Neuromodulation Medical tech's on a roll, and Cala Health just hopped on the fast track with their latest launch—the Cala kIQ Plus System. This bad boy is aiming to offer relief for those grappling with hand tremors, thanks to its FDA clearance and a host of new features. It's the first of its kind, combining multiple therapy modes with an...

Bob Evans' Protein Mac & Cheese: Practical Power Play

Has anyone else noticed just how fast the world spins when it comes to consumer trends these days? Bob Evans is hopping right on the protein bandwagon with its latest launch, a microwave-ready Protein Macaroni & Cheese that packs 18 grams of protein per serving. You gotta hand it to them for seizing opportunity when they see it. This one's not just about tossing a new...

Dentistry.One Achieves HITRUST i1, Boosts Cybertrust

HITRUST i1 Certification: The Gold Standard in Security For a world increasingly reliant on digital infrastructure, cybersecurity certification is no longer just a badge of honor; it's a cornerstone of trust. Dentistry.One nailed this down by bagging that coveted HITRUST i1 certification. When folks talk about securing data, HITRUST might as well be speaking gospel. We're...

Cure Blindness Project's 770K Screenings for World Sight Day

Visionary Steps Toward a Brighter Future No two words could describe the task that Cure Blindness Project is tackling this year: vision and action. Marking World Sight Day on October 8, they plan to usher in 770,000 eye screenings across Asia, Africa, and the Caribbean. These initiatives aren't just numbers—they're a colossal step toward lifting the veil of avoidable...

ROKFORM’s Signal Card: A Wallet Tracker for All

The Gadget You Didn't Know You Needed Ever feel that momentary panic when your wallet seems to have vanished into thin air? ROKFORM's fresh offering, the Signal Card, tackles that heart-stopping moment head-on. They've taken the mundane act of misplacing your wallet and transformed it with their sleek, credit-card-sized tracker. This baby pairs seamlessly with Apple Find...

Navigating Holiday Sweets: Healthy Balancing Acts

In the middle of the sweet madness that is the holiday season, Crispy Green and Dr. Nicole Avena are playing guide to families drowning in sugar. This isn't just a once-a-year Halloween headache; we're starting that sugar spiral early and letting it ride until the New Year approaches. It's an all-hands-on-deck situation if families want to dodge that sugar overload. Why...